Abstract |
Sarcopenia is the age-related loss of muscle mass and function and no pharmacological medication has been approved for its treatment. We established an atrogin-1/MAFbx promoter assay to find drug candidates that inhibit myotube atrophy. Alverine citrate (AC) was identified using high-throughput screening of an existing drug library. AC is an established medicine for stomach and intestinal spasms. AC treatment increased myotube diameter and inhibited atrophy signals induced by either C26-conditioned medium or dexamethasone in cultured C2C12 myoblasts. AC also enhanced myoblast fusion through the upregulation of fusion-related genes during C2C12 myoblast differentiation. Oral administration of AC improves muscle mass and physical performance in aged mice, as well as hindlimb-disused mice. Taken together, our data suggest that AC may be a novel therapeutic candidate for improving muscle weakness, including sarcopenia.
|
Authors | Jong Hyeon Yoon, Seung-Min Lee, Younglang Lee, Min Ju Kim, Jae Won Yang, Jeong Yi Choi, Ju Yeon Kwak, Kwang-Pyo Lee, Yong Ryoul Yang, Ki-Sun Kwon |
Journal | Biochemical and biophysical research communications
(Biochem Biophys Res Commun)
Vol. 586
Pg. 157-162
(01 01 2022)
ISSN: 1090-2104 [Electronic] United States |
PMID | 34847441
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved. |
Chemical References |
- Biomarkers
- Cadherins
- Cav3 protein, mouse
- Caveolin 3
- Cdh2 protein, mouse
- Integrin beta1
- Itgb1 protein, mouse
- Parasympatholytics
- Propylamines
- alverine
- Dexamethasone
|
Topics |
- Aging
(genetics, metabolism)
- Animals
- Biomarkers
(metabolism)
- Cadherins
(genetics, metabolism)
- Caveolin 3
(genetics, metabolism)
- Cell Differentiation
(drug effects)
- Cell Line
- Dexamethasone
(pharmacology)
- Disease Models, Animal
- Gene Expression
- High-Throughput Screening Assays
- Immobilization
- Integrin beta1
(genetics, metabolism)
- Mice
- Mice, Inbred C57BL
- Muscle Development
(genetics)
- Muscle Fibers, Skeletal
(drug effects, metabolism, pathology)
- Muscle Strength
(drug effects)
- Muscle, Skeletal
(drug effects, metabolism, pathology)
- Muscular Atrophy
(genetics, metabolism, pathology, prevention & control)
- Myoblasts
(drug effects, metabolism, pathology)
- Parasympatholytics
(pharmacology)
- Propylamines
(pharmacology)
- Sarcopenia
(genetics, metabolism, pathology, prevention & control)
|